P300 Latency with Memory Performance: A Promising Biomarker for Preclinical Stages of Alzheimer's Disease

Overview

Journal Biosensors (Basel)

Specialty Biotechnology

Date 2024 Dec 27

PMID 39727881

Authors

Manal Mohamed

Nourelhuda Mohamed

Jae Gwan Kim

Affiliations

Soon will be listed here.

Abstract

Detecting and tracking the preclinical stages of Alzheimer's disease (AD) is now of particular interest due to the aging of the world's population. AD is the most common cause of dementia, affecting the daily lives of those afflicted. Approaches in development can accelerate the evaluation of the preclinical stages of AD and facilitate early treatment and the prevention of symptom progression. Shifts in P300 amplitude and latency, together with neuropsychological assessments, could serve as biomarkers in the early screening of declines in cognitive abilities. In this study, we investigated the ability of the P300 indices evoked during a visual oddball task to differentiate pre-clinically diagnosed participants from normal healthy adults (HCs). Two preclinical stages, named asymptomatic AD (AAD) and prodromal AD (PAD), were included in this study, and a total of 79 subjects participated, including 35 HCs, 22 AAD patients, and 22 PAD patients. A mixed-design ANOVA test was performed to compare the P300 indices among groups during the processing of the target and non-target stimuli. Additionally, the correlation between these neurophysiological variables and the neuropsychological tests was evaluated. Our results revealed that neither the peak amplitude nor latency of P300 can distinguish AAD from HCs. Conversely, the peak latency of P300 can be used as a biomarker to differentiate PAD from AAD and HCs. The correlation results revealed a significant relationship between the peak latency of P300 and memory domain tasks, showing that less time-demanding neuropsychological assessments can be used. In summary, our findings showed that a combination of P300 latency and memory-requiring tasks can be used as an efficient biomarker to differentiate individuals with AAD from HCs.

References

Frodl T, Hampel H, Juckel G, Burger K, Padberg F, Engel R . Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease. Psychophysiology. 2002; 39(2):175-81. DOI: 10.1017/S0048577202010260. View

Li X, Shao X, Wang N, Wang T, Chen G, Zhou H . Correlation of auditory event-related potentials and magnetic resonance spectroscopy measures in mild cognitive impairment. Brain Res. 2010; 1346:204-12. DOI: 10.1016/j.brainres.2010.04.078. View

Hirata K, Hozumi A, Tanaka H, Kubo J, Zeng X, Yamazaki K . Abnormal information processing in dementia of Alzheimer type. A study using the event-related potential's field. Eur Arch Psychiatry Clin Neurosci. 2000; 250(3):152-5. DOI: 10.1007/s004060070033. View

van Deursen J, Vuurman E, Smits L, Verhey F, Riedel W . Response speed, contingent negative variation and P300 in Alzheimer's disease and MCI. Brain Cogn. 2009; 69(3):592-9. DOI: 10.1016/j.bandc.2008.12.007. View

Caselli R, Dueck A, Locke D, Hoffman-Snyder C, Woodruff B, Rapcsak S . Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology. 2011; 76(16):1383-8. PMC: 3087407. DOI: 10.1212/WNL.0b013e3182167147. View

Berent S, Giordani B, Foster N, Minoshima S, Lajiness-ONeill R, Koeppe R . Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res. 1999; 33(1):7-16. DOI: 10.1016/s0022-3956(98)90048-6. View

Marsh J, Schubarth G, BROWN W, Riege W, Strandburg R, Dorsey D . PET and P300 relationships in early Alzheimer's disease. Neurobiol Aging. 1990; 11(4):471-6. DOI: 10.1016/0197-4580(90)90015-r. View

Bennys K, Portet F, Touchon J, Rondouin G . Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol. 2007; 24(5):405-12. DOI: 10.1097/WNP.0b013e31815068d5. View

Li J, Broster L, Jicha G, Munro N, Schmitt F, Abner E . A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimers Res Ther. 2017; 9(1):3. PMC: 5244569. DOI: 10.1186/s13195-016-0229-3. View

10.

Pedroso R, Fraga F, Corazza D, Andreatto C, Coelho F, Costa J . P300 latency and amplitude in Alzheimer's disease: a systematic review. Braz J Otorhinolaryngol. 2012; 78(4):126-32. PMC: 9446362. View

11.

Azizian A, Polich J . Evidence for attentional gradient in the serial position memory curve from event-related potentials. J Cogn Neurosci. 2007; 19(12):2071-81. PMC: 2748728. DOI: 10.1162/jocn.2007.19.12.2071. View

12.

Mudar R, Chiang H, Eroh J, Nguyen L, Maguire M, Spence J . The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials. J Alzheimers Dis. 2016; 50(2):577-90. DOI: 10.3233/JAD-150586. View

13.

Demirayak P, Kiyi I, Isbitiren Y, Yener G . Cognitive load associates prolonged P300 latency during target stimulus processing in individuals with mild cognitive impairment. Sci Rep. 2023; 13(1):15956. PMC: 10518304. DOI: 10.1038/s41598-023-43132-8. View

14.

Cespon J, Galdo-Alvarez S, Pereiro A, Diaz F . Differences between mild cognitive impairment subtypes as indicated by event-related potential correlates of cognitive and motor processes in a Simon task. J Alzheimers Dis. 2014; 43(2):631-47. DOI: 10.3233/JAD-132774. View

15.

Stothart G, Kazanina N, Naatanen R, Haworth J, Tales A . Early visual evoked potentials and mismatch negativity in Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis. 2014; 44(2):397-408. DOI: 10.3233/JAD-140930. View

16.

Cummings J, Dubois B, Molinuevo J, Scheltens P . International Work Group criteria for the diagnosis of Alzheimer disease. Med Clin North Am. 2013; 97(3):363-8. DOI: 10.1016/j.mcna.2013.01.001. View

17.

Lai C, Lin R, Liou L, Liu C . The role of event-related potentials in cognitive decline in Alzheimer's disease. Clin Neurophysiol. 2009; 121(2):194-9. DOI: 10.1016/j.clinph.2009.11.001. View

18.

Li B, Tang H, Chen S . Retrieval Deficiency in Brain Activity of Working Memory in Amnesic Mild Cognitive Impairment Patients: A Brain Event-Related Potentials Study. Front Aging Neurosci. 2016; 8:54. PMC: 4803731. DOI: 10.3389/fnagi.2016.00054. View

19.

Asaumi Y, Morita K, Nakashima Y, Muraoka A, Uchimura N . Evaluation of P300 components for emotion-loaded visual event-related potential in elderly subjects, including those with dementia. Psychiatry Clin Neurosci. 2014; 68(7):558-67. DOI: 10.1111/pcn.12162. View

20.

Chen P, Ratcliff G, Belle S, Cauley J, DeKosky S, Ganguli M . Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2001; 55(12):1847-53. DOI: 10.1212/wnl.55.12.1847. View